HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xi Lin Selected Research

Jervell-Lange Nielsen Syndrome (Jervell and Lange-Nielsen Syndrome)

1/2021Gene therapy via canalostomy approach preserves auditory and vestibular functions in a mouse model of Jervell and Lange-Nielsen syndrome type 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xi Lin Research Topics

Disease

41Neoplasms (Cancer)
04/2022 - 01/2006
18Deafness (Deaf Mutism)
01/2021 - 07/2003
16Infections
12/2021 - 03/2003
12Neoplasm Metastasis (Metastasis)
01/2022 - 08/2012
12Inflammation (Inflammations)
01/2022 - 11/2012
9Body Weight (Weight, Body)
01/2022 - 06/2005
8Carcinogenesis
01/2022 - 07/2002
8Breast Neoplasms (Breast Cancer)
01/2021 - 05/2011
7Thrombosis (Thrombus)
11/2020 - 06/2005
7Hearing Loss (Hearing Impairment)
01/2020 - 07/2008
7Disseminated Intravascular Coagulation
06/2017 - 11/2007
6Wounds and Injuries (Trauma)
06/2019 - 12/2002
5Necrosis
01/2022 - 07/2014
5Hemorrhage
06/2019 - 12/2002
3Virus Diseases (Viral Diseases)
12/2022 - 01/2017
3Hyperthermia
08/2022 - 03/2017
3Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 01/2020
3Prostatic Neoplasms (Prostate Cancer)
12/2020 - 01/2006
3Heart Failure
03/2016 - 01/2015
2Adenocarcinoma of Lung
02/2022 - 02/2007
2Brain Edema (Cerebral Edema)
02/2022 - 02/2020
2Demyelinating Diseases (Demyelinating Disease)
02/2022 - 02/2006
2Multiple Myeloma
01/2022 - 01/2020
2Dysbiosis
01/2022 - 10/2018
2Arthritis (Polyarthritis)
12/2021 - 01/2020
2Osteoporosis
12/2021 - 05/2005
2Tinnitus
05/2021 - 05/2003
2Bacterial Infections (Bacterial Infection)
01/2021 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2018
2Huntington Disease (Huntington's Disease)
12/2020 - 01/2020
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2020 - 06/2008
2Pulmonary Embolism
11/2020 - 02/2011
2Melanoma (Melanoma, Malignant)
01/2020 - 01/2020
2Carcinoma (Carcinomatosis)
01/2020 - 08/2012
2Lymphoma (Lymphomas)
08/2019 - 10/2017
2Rupture
06/2019 - 02/2018
2Pancreatitis
10/2018 - 10/2010

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
12/2022 - 07/2002
14Pharmaceutical PreparationsIBA
01/2022 - 02/2007
10Messenger RNA (mRNA)IBA
01/2022 - 08/2013
9ConnexinsIBA
01/2015 - 07/2003
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 08/2012
7MicroRNAs (MicroRNA)IBA
11/2020 - 03/2013
7Dacarbazine (DIC)FDA LinkGeneric
06/2017 - 11/2007
7LipopolysaccharidesIBA
06/2017 - 11/2007
6Biomarkers (Surrogate Marker)IBA
01/2020 - 05/2011
6EnzymesIBA
01/2020 - 11/2007
6CytokinesIBA
12/2017 - 08/2013
5Therapeutic UsesIBA
02/2022 - 11/2016
5Peptides (Polypeptides)IBA
01/2022 - 03/2016
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 02/2007
4Bortezomib (Velcade)FDA Link
01/2022 - 10/2018
4Proteasome InhibitorsIBA
01/2022 - 10/2018
4CateninsIBA
01/2022 - 01/2016
4Cadherins (E-Cadherin)IBA
01/2020 - 03/2016
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 06/2010
4AntigensIBA
01/2019 - 03/2003
4ParaffinIBA
11/2016 - 05/2011
4VenomsIBA
01/2015 - 11/2007
4FIIaIBA
10/2012 - 06/2005
3CholesterolIBA
08/2022 - 07/2016
3ethylene dichloride (1,2-dichloroethane)IBA
02/2022 - 02/2020
3Biological ProductsIBA
12/2021 - 05/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2016
3ChloridesIBA
12/2020 - 02/2016
3Chloride Channels (Chloride Channel)IBA
12/2020 - 08/2013
3Phosphotransferases (Kinase)IBA
08/2019 - 05/2012
3Protein Kinases (Protein Kinase)IBA
11/2016 - 05/2012
3LipidsIBA
05/2014 - 05/2011
3Connexin 26IBA
02/2009 - 01/2006
2Oxidoreductases (Dehydrogenase)IBA
08/2022 - 10/2020
2Indicators and Reagents (Reagents)IBA
03/2022 - 06/2018
2Aquaporin 4IBA
02/2022 - 02/2020
2Diphosphonates (Bisphosphonates)IBA
01/2022 - 11/2013
2LigandsIBA
01/2022 - 01/2020
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2022 - 05/2014
2Immunoglobulin G (IgG)IBA
12/2021 - 12/2012
2Capsules (Microcapsules)IBA
05/2021 - 05/2011
2florfenicolIBA
01/2021 - 01/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2019
2MetalsIBA
01/2021 - 10/2019
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2020 - 01/2020
2Sirtuin 1IBA
11/2020 - 01/2019
2hydroxypropyl methacrylateIBA
10/2020 - 10/2019
2Small Interfering RNA (siRNA)IBA
01/2020 - 01/2020
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2020 - 10/2016
2RNA (Ribonucleic Acid)IBA
01/2020 - 10/2016
2IronIBA
01/2020 - 03/2003
2Long Noncoding RNAIBA
01/2020 - 01/2020
2Adenosine Triphosphate (ATP)IBA
05/2019 - 01/2016
2Taurocholic Acid (Sodium Taurocholate)IBA
10/2018 - 10/2010
2Antiviral Agents (Antivirals)IBA
10/2018 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
10/2018 - 07/2016
24,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA
07/2018 - 01/2016

Therapy/Procedure

17Therapeutics
12/2021 - 05/2005
5Ligation
06/2019 - 12/2002
3Drug Therapy (Chemotherapy)
02/2022 - 12/2015
3Operative Surgical Procedures
01/2015 - 12/2002
2Oral Administration
01/2022 - 10/2014
2Aftercare (After-Treatment)
01/2019 - 06/2008